Tianjin Ringpu Bio-Technology Co.,Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 442.78 million compared to CNY 390.81 million a year ago. Revenue was CNY 442.78 million compared to CNY 390.81 million a year ago.

Net income was CNY 80.82 million compared to CNY 72.21 million a year ago. Basic earnings per share from continuing operations was CNY 0.1742 compared to CNY 0.1564 a year ago. Diluted earnings per share from continuing operations was CNY 0.1742 compared to CNY 0.1564 a year ago.